Compare NBIX & EMBJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | EMBJ |
|---|---|---|
| Founded | 1992 | 1969 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.9B |
| IPO Year | 1996 | N/A |
| Metric | NBIX | EMBJ |
|---|---|---|
| Price | $128.55 | $57.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 1 |
| Target Price | ★ $175.23 | $84.00 |
| AVG Volume (30 Days) | ★ 1.2M | 952.7K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 4.67 | N/A |
| Revenue | ★ $161,626,000.00 | N/A |
| Revenue This Year | $22.85 | N/A |
| Revenue Next Year | $9.99 | $11.87 |
| P/E Ratio | ★ $27.75 | $159.30 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $84.23 | $59.73 |
| 52 Week High | $160.18 | $80.75 |
| Indicator | NBIX | EMBJ |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 29.43 |
| Support Level | $122.82 | N/A |
| Resistance Level | $128.99 | $65.81 |
| Average True Range (ATR) | 2.97 | 2.68 |
| MACD | 0.12 | -1.23 |
| Stochastic Oscillator | 23.91 | 2.07 |
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.